AMP 2023: Discover Tumor Heterogeneity with Integrated Single-Cell Genomics and Transcriptomics
BioSkryb Genomics, Inc.
0:00 / 0:00
AMP 2023: Discover Tumor Heterogeneity with Integrated Single-Cell Genomics and Transcriptomics
26 просмотров · 13 дней назад
BioSkryb Genomics, Inc.
56 подписчиков
26 просмотров · 13 дней назад
In this workshop, learn how ResolveOME™, an integrated single-cell genomic and transcriptomic workflow, was used to characterize intratumoral heterogeneity in ductal carcinoma in situ cells.